Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000093751-22-000360
Filing Date
2022-02-14
Accepted
2022-02-11 21:12:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 VANDA_PHARMACEUTICALS_INC.txt SC 13G/A 6634
  Complete submission text file 0000093751-22-000360.txt   8480
Mailing Address ONE LINCOLN STREET BOSTON MA 02111
Business Address ONE LINCOLN STREET BOSTON MA 02111 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82196 | Film No.: 22624198
SIC: 2834 Pharmaceutical Preparations